GlassScriptPhysician profile
Theresa Bishop
NPI 1659304483
$1,217.93
in general payments reported to CMS, 2019-2025
25 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.04 · 2020: $95.54 · 2021: $235 · 2022: $256 · 2023: $232 · 2024: $159 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $371.33 | 2021-2025 | Vraylar |
| Abbott Laboratories | $111.99 | 2019-2023 | Freestyle Libre 2 |
| Takeda Pharmaceuticals U.S.A., INC. | $100.90 | 2022-2025 | Trintellix, Hyqvia |
| Otsuka America Pharmaceutical, INC. | $96.40 | 2020-2023 | Rexulti, Nuedexta |
| Amgen INC. | $80.58 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $57.78 | 2020-2025 | Spravato, Invega Sustenna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.44 | 2019-2025 | Xifaxan |
| Novo Nordisk INC | $34.75 | 2019-2023 | Wegovy |
| Medtronic, INC. | $31.56 | 2021 | |
| Eisai INC. | $27.05 | 2025 | |
| Abiomed | $24.88 | 2024 | Impella |
| Irhythm Technologies, INC. | $23.90 | 2022 | |
| Lundbeck LLC | $23.63 | 2023 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $21.46 | 2022 | |
| Supernus Pharmaceuticals, INC. | $19.19 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.40 | 2022 | |
| Mylan Specialty L.P. | $17.22 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.09 | 2019 | |
| Hologic Sales and Service, LLC | $13.84 | 2021 | |
| Allergan, INC. | $13.62 | 2020 | |
| Corcept Therapeutics | $13.42 | 2024 | Korlym |
| Antares Pharma, INC. | $13.20 | 2021 | |
| Bausch & Lomb Americas INC. | $13.03 | 2023 | Vyzulta |
| Shire North American Group INC | $11.85 | 2019 | |
| Nestle Healthcare Nutrition INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theresa Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.